Community post

The Japanese government is moving forward with a pull incentive for developing new antibiotics, called the Antimicrobial Securement Project. According to CARB-X's director, Kevin Outterson, this is a revenue guarantee pull incentive, akin to what Sweden is doing, but higher in funding amount, and is an exciting step in the right direction.